These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38642509)
1. Exosome secretion related gene signature predicts chemoresistance in patients with colorectal cancer. Ming L; Tang J; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y Pathol Res Pract; 2024 May; 257():155313. PubMed ID: 38642509 [TBL] [Abstract][Full Text] [Related]
2. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer. Zhang C; Zeng C; Xiong S; Zhao Z; Wu G Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388 [TBL] [Abstract][Full Text] [Related]
3. A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer. Li L; Li Y; Lin J; Pang W Technol Cancer Res Treat; 2024; 23():15330338241277584. PubMed ID: 39155627 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
5. A CLRN3-Based CD8 Gong Z; Huang X; Cao Q; Wu Y; Zhang Q Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of an immune prognostic signature in colorectal cancer. Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer. Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777 [TBL] [Abstract][Full Text] [Related]
8. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients. Shen KY; Chen BY; Gao WC Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507 [TBL] [Abstract][Full Text] [Related]
9. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer. Chen Q; Tang P; Huang H; Qiu X Front Immunol; 2022; 13():934124. PubMed ID: 35958575 [TBL] [Abstract][Full Text] [Related]
11. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
12. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
13. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer. Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J Front Immunol; 2021; 12():736030. PubMed ID: 34659224 [TBL] [Abstract][Full Text] [Related]
17. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. Wang H; Wang W; Wang Z; Li X Front Immunol; 2023; 14():1291859. PubMed ID: 38143740 [TBL] [Abstract][Full Text] [Related]
18. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer. Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z Front Immunol; 2022; 13():951455. PubMed ID: 36189298 [TBL] [Abstract][Full Text] [Related]
19. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer. Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416 [TBL] [Abstract][Full Text] [Related]
20. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]